Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The aim of this randomized, double-blind, crossover absorption study was to compare the absorption of a liposomal vitamin D3 formulation (Cymbiotika) with that of a conventional non-liposomal vitamin D3 formulation.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Enhanced acute absorption of vitamin D3 with a liposomal formulation (Cymbiotika) compared to a standard formulation in healthy adults: a randomized double-blind crossover study
Source: Article title.
Participants were randomized to receive either the liposomal (Cymbiotika) formulation followed by the comparator formulation or vice versa.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Enhanced acute absorption of vitamin D3 with a liposomal formulation (Cymbiotika) compared to a standard formulation in healthy adults: a randomized double-blind crossover study
Study design awaiting verification · Frontiers in Nutrition · 2026
Original publication title
Enhanced acute absorption of vitamin D3 with a liposomal formulation (Cymbiotika) compared to a standard formulation in healthy adults: a randomized double-blind crossover study
Copyright © 2026 Briskey, Rahman, Raut, Jafarieh and Rao.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Vitamin D deficiency is increasingly prevalent and linked to impaired health and disease. While vitamin D3 supplementation is effective, variability in absorption can influence bioavailability and clinical responses, with formulation characteristics potentially contributing to this variability.
Source: BackgroundAbstract: What methods does the paper describe?
The aim of this randomized, double-blind, crossover absorption study was to compare the absorption of a liposomal vitamin D3 formulation (Cymbiotika) with that of a conventional non-liposomal vitamin D3 formulation. Healthy adult participants received a single oral dose of both formulations in random order separated by a 2-week washout period. Blood samples were collected over 48 h post-dose and plasma cholecalciferol concentrations quantified. Absorption parameters including area under the concentration-time curve (AUC), maximum plasma concentration (Cmax), and time to peak concentration (Tmax) were calculated following baseline correction.
Source: MethodAbstract: Results
Twelve participants completed the study (mean age 34.3 ± 9.7 years; BMI 24.8 ± 2.7 kg/m2). The liposomal formulation showed greater systemic absorption compared with the comparator formulation, with a 1.9-fold higher AUC (199 vs. 106 ng·h/mL). Peak concentration was also higher for the liposomal formulation (8.4 vs. 6.0 ng/mL). Circulating cholecalciferol concentrations remained elevated above baseline at 48 h in the liposomal formulation but returned to baseline in the comparator formulation.
Source: ResultsAbstract: Conclusion
These findings suggest that the Cymbiotika formulation may enhance the acute absorption of orally administered vitamin D3. Whether this enhanced acute absorption translates into improved long-term vitamin D status requires investigation in longer-term supplementation studies.
Source: ConclusionAuthors’ abstract
Background
Vitamin D deficiency is increasingly prevalent and linked to impaired health and disease. While vitamin D3 supplementation is effective, variability in absorption can influence bioavailability and clinical responses, with formulation characteristics potentially contributing to this variability.
Method
The aim of this randomized, double-blind, crossover absorption study was to compare the absorption of a liposomal vitamin D3 formulation (Cymbiotika) with that of a conventional non-liposomal vitamin D3 formulation. Healthy adult participants received a single oral dose of both formulations in random order separated by a 2-week washout period. Blood samples were collected over 48 h post-dose and plasma cholecalciferol concentrations quantified. Absorption parameters including area under the concentration-time curve (AUC), maximum plasma concentration (Cmax), and time to peak concentration (Tmax) were calculated following baseline correction.
Results
Twelve participants completed the study (mean age 34.3 ± 9.7 years; BMI 24.8 ± 2.7 kg/m2). The liposomal formulation showed greater systemic absorption compared with the comparator formulation, with a 1.9-fold higher AUC (199 vs. 106 ng·h/mL). Peak concentration was also higher for the liposomal formulation (8.4 vs. 6.0 ng/mL). Circulating cholecalciferol concentrations remained elevated above baseline at 48 h in the liposomal formulation but returned to baseline in the comparator formulation.
Conclusion
These findings suggest that the Cymbiotika formulation may enhance the acute absorption of orally administered vitamin D3. Whether this enhanced acute absorption translates into improved long-term vitamin D status requires investigation in longer-term supplementation studies.
Clinical trial registration
https://doi.org/10.1186/ISRCTN39055102, identifier (ISRCTN39055102).
Publication and source details
Original title: Enhanced acute absorption of vitamin D3 with a liposomal formulation (Cymbiotika) compared to a standard formulation in healthy adults: a randomized double-blind crossover study
David Briskey; Sandra Rahman; Shilpa Raut; Chervin Jafarieh; Amanda Rao
Frontiers in Nutrition · 2026
* Correspondence: Amanda Rao, amanda@rdcglobal.com.auCopyright © 2026 Briskey, Rahman, Raut, Jafarieh and Rao.2026Briskey, Rahman, Raut, Jafarieh and Raohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. The study was funded by Cymbiotika LLC, California, USA. The funder had no involvement in the the study design, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-07T18:03:41+00:00
DOI: 10.3389/fnut.2026.1858064 · PMC13710289